First Time Loading...

Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 14.97 AUD -0.53% Market Closed
Updated: May 7, 2024

Telix Pharmaceuticals Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Telix Pharmaceuticals Ltd
Cash from Operating Activities Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
PYC

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Telix Pharmaceuticals Ltd
ASX:TLX
Cash from Operating Activities
AU$23.9m
CAGR 3-Years
130%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Cash from Operating Activities
-AU$35.4m
CAGR 3-Years
-34%
CAGR 5-Years
-29%
CAGR 10-Years
-10%
Mesoblast Ltd
ASX:MSB
Cash from Operating Activities
-$59.1m
CAGR 3-Years
16%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Cash from Operating Activities
$2.7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
9%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cash from Operating Activities
AU$42.3m
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Cash from Operating Activities
-AU$19.4m
CAGR 3-Years
-23%
CAGR 5-Years
-46%
CAGR 10-Years
-22%

See Also

What is Telix Pharmaceuticals Ltd's Cash from Operating Activities?
Cash from Operating Activities
23.9m AUD

Based on the financial report for Dec 31, 2023, Telix Pharmaceuticals Ltd's Cash from Operating Activities amounts to 23.9m AUD.

What is Telix Pharmaceuticals Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
130%

The average annual Cash from Operating Activities growth rates for Telix Pharmaceuticals Ltd have been 130% over the past three years .